MANGOCEUTICALS, INC. Files 8-K: Material Agreement, Debt, Equity Sales
Ticker: MGRX · Form: 8-K · Filed: Apr 17, 2025 · CIK: 1938046
| Field | Detail |
|---|---|
| Company | Mangoceuticals, INC. (MGRX) |
| Form Type | 8-K |
| Filed Date | Apr 17, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, financial-obligation, equity-sale
TL;DR
MANGOCEUTICALS just dropped an 8-K: new deal, debt, and sold some stock. Watch this space.
AI Summary
On April 11, 2025, MANGOCEUTICALS, INC. entered into a material definitive agreement. The company also reported the creation of a direct financial obligation and unregistered sales of equity securities. The filing includes financial statements and exhibits.
Why It Matters
This 8-K filing indicates significant corporate actions by MANGOCEUTICALS, INC., including new financial obligations and equity transactions, which could impact its financial structure and shareholder value.
Risk Assessment
Risk Level: medium — The filing details material definitive agreements, financial obligations, and unregistered equity sales, suggesting potential financial shifts and increased complexity for the company.
Key Players & Entities
- MANGOCEUTICALS, INC. (company) — Registrant
- April 11, 2025 (date) — Date of Earliest Event Reported
- Texas (location) — State of Incorporation
- 001-41615 (identifier) — SEC File Number
- 87-3841292 (identifier) — IRS Employer Identification No.
- 15110 N. Dallas Parkway , Suite 600 Dallas , Texas 75248 (address) — Principal executive offices
FAQ
What type of material definitive agreement did MANGOCEUTICALS, INC. enter into?
The filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in the provided text.
What is the nature of the direct financial obligation created by MANGOCEUTICALS, INC.?
The filing states the creation of a direct financial obligation, but the specific terms and amount of the obligation are not detailed in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on April 11, 2025.
What is MANGOCEUTICALS, INC.'s state of incorporation and SEC file number?
MANGOCEUTICALS, INC. is incorporated in Texas and has an SEC file number of 001-41615.
Does the filing mention any unregistered sales of equity securities?
Yes, the filing explicitly lists 'Unregistered Sales of Equity Securities' as an item of information.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 17, 2025 regarding MANGOCEUTICALS, INC. (MGRX).